Problems of evidence-based medicine in psychopharmacotherapy: Problems of evidence grading and of the evidence basis for complex clinical decision making;Probleme der "evidence-based medicine" in der psychopharmakotherapie: Problematik der evidenzgraduierung und der evidenzbasierung komplexer klinischer entscheidungsprozesse

Nervenarzt

Volumn 78, Issue 9, 2007, Pages 1014-1027

  Moller H J ^a   Maier, W ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Evidence based; Evidence rating; Guidelines; Psychopharmacotherapy

Indexed keywords

ANTIDEPRESSANT AGENT;

BIPOLAR DEPRESSION; CLINICAL DECISION MAKING; CLINICAL RESEARCH; EVIDENCE BASED MEDICINE; HEALTH CARE SYSTEM; HUMAN; MENTAL HEALTH CARE; PRACTICE GUIDELINE; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REVIEW;

CLINICAL TRIALS AS TOPIC; DECISION SUPPORT SYSTEMS, CLINICAL; EVIDENCE-BASED MEDICINE; GERMANY; META-ANALYSIS AS TOPIC; PSYCHOPHARMACOLOGY;

EID: 34548585876     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-007-2291-3     Document Type: Review

References (97)

1. Adli M, Bauer M, Rush AJ (2006) Algorithms and collaborative-care systems for depression: are they effective and why? A systematic review. Biol Psychiatry 59: 1029-1038
2. Adli M, Rush J, Möller HJ, Bauer M (2003) Algorithms for optimizing the treatment of depression: making the right decision at the right time. Pharmacopsychiatry (Suppl 3) 36: S222-S229
3. Altshuler L, Suppes T, Black D et al. (2003) Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry 160: 1252-1262
4. American Psychiatric Association. APA Guideline Development Process. http://www.psychorg/psych_pract/treatg/pg/prac_guidecfm 2006
5. Antes G (2004) The evidence base of clinical practice guidelines, health technology assessments and patient information as a basis for clinical decision-making. Z Ärztl Fortbild Qualitätssich 98: 180-184
6. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Deutsches Instrument zur methodischen Leitlinien-Bewertung (DELBI). www.delbi.de 2006
7. Atkins D, Best D, Briss PA et al. (2004) Grading quality of evidence and strength of recommendations. BMJ 19: 1490
8. Baldwin D, Broich K, Fritze J et al. (2003) Placebo-controlled studies in depression: necessary, ethical and feasible. Eur Arch Psychiatry Clin Neurosci 253: 22-28
9. Bandelow B, Zohar J, Hollander E et al., WFSBP Task Force on Treatment Guidelines for Anxiety O-CaPSD (2003) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders. World J Biol Psychiatry 3: 171-199
10. Bauer M, Whybrow PC, Angst J (2002) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. World J Biol Psychiatry 3: 69-86
11. Bauer M, Whybrow PC, Angst J et al., WFSBP Task Force on Treatment Guidelines for Unipolar Depressive Disorders (2002) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 3: 5-43
12. Bottlender R, Rudolf D, Jager M et al. (2002) Are bipolar I depressive patients less responsive to treatment with antidepressants than unipolar depressive patients? Results from a case control study. Eur Psychiatry 17: 200-205
13. Bottlender R, Rudolf D, Strauss A, Moller HJ (1998) Antidepressant- associated maniform states in acute treatment of patients with bipolar-I depression. Eur Psychiatry 248: 296-300
14. Boyd CM, Darer J, Boult C et al. (2005) Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 294: 716-724
15. Campbell M, Fitzpatrick R, Haines A et al. (2000) Framework for design and evaluation of complex interventions to improve health. BMJ 321: 694-696
16. Carpenter WT (2001) Evidence-based treatment for first-episode schizophrenia? Am J Psychiatry 158: 1771-1773
17. Cartabellotta A, Minella C, Bevilacqua L, Caltagirone P (1998) Evidence-based medicine. 3. Systematic reviews: a tool for clinical practice, permanent education and health policy decisions. Italian Group on Evidence-Based Medicine-GIMBE. Recenti Prog Med 89: 329-337
18. Cartabellotta A, Montalto G, Notarbartolo A (1998) Evidence-based medicine. How to use biomedical literature to solve clinical problems. Italian Group on Evidence-Based Medicine-GIMBE. Minerva Med 89: 105-115
19. Clark W, Mucklow J (1998) Gathering and weighing the evidence. In: Panton R, Chapman S (eds) Medicines Management. BMJ Books and Pharmaceutical Press, London, pp 59-74
20. Committee for Proprietary Medicinal Products (CPMP) (2002) Note for guidance on clinical investigation of medicinal products in the treatment of depression. http://www.emea.eu.int 2002
21. Craig JC, Irwig LM, Stockler MR (2001) Evidence-based medicine:useful tools for decision making. MJA 174: 248-253
22. Czekalla J (2006) Kritische Bewertung von Studien und Metaanalysen. Ein Fortbildungsartikel über die wichtigsten Validitätskriterien der Evidence-based Medicine. Psychopharmakotherapie 13: 224-230
23. Eccles M, Grimshaw J, Campbell M, Ramsay C (2003) Research designs for studies evaluating the effectiveness of change and improvement strategies. Qual Saf Health Care 12: 47-52
24. Falkai P, Wobrock T, Lieberman J et al. (2005) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia. World J Biol Psychiatry 6: 132-191
25. Falkai P, Wobrock T, Lieberman J et al. (2006) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia. World J Biol Psychiatry 7: 5-40
26. Fava M, Rush AJ, Trivedi MH et al. (2003) Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am 26: 457-494
27. Fava M, Rush AJ, Wisniewski SR et al. (2006) A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. Am J Psychiatry 163: 1161-1172
28. Ferreira PH (2002) Effect of applying different.,levels of evidence" criteria on conclusions of Cochrane reviews of interventions for low back pain. J Clin Epidemiol 55: 1126-1129
29. Fritze J, Aldenhoff J, Bergmann F et al. (2007) Hinweise der AkdÄ und KBV zu Quetiapin und anderen modernen Antipsychotika: Richtigstellung der DGPPN. Psychoneuro 33: 31-32
30. Fritze J, Möller HJ (2001) Design of clinical trials of antidepressants. Should a placebo control arm be included? CNS Drugs 15: 755-764
31. Gaebel W (1996) Leitfaden zur Qualitätsbeurteilung in Psychiatrischen Kliniken. Stellungnahme für die DGPPN aus Sicht des Referates.,Qualitätssicherung". Nervenarzt 67: 968-970
32. Gaebel W, Falkai P (1998) Praxisleitlinien in Psychiatrie und Psychotherapie: Behandlungsleitlinie Schizophrenie. Steinkopff, Darmstadt
33. Gaebel W, Falkai P (2003) DGPPN-Referat Qualitätssicherung und Leitlinien. Aktueller Stand und Perspektiven der Leitlinienentwicklung. Nervenarzt 74: 94-96
34. Gaebel W, Falkai P, Weinmann S, Wobrock T (2006) S3-Praxisleitlinien in Psychiatrie und Psychotherapie. Band 1: Behandlungsleitlinie Schizophrenie. Steinkopff, Darmstadt
35. Geddes J et al. (2006) Metaanalysis of lamotrigine studies on the acute treatment of bipolar disorder. Poster presented at the ISBD Regional Meeting, 2-4 August 2006, Edinburgh
36. Gerson S, Belin TR, Kaufman A et al. (1999) Pharmacological and psychological treatments for depressed older patients: a meta-analysis and overview of recent findings. Harv Rev Psychiatry 7: 1-28
37. Gijsman HJ, Geddes JR, Rendell JM et al. (2004) Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry 161: 1537-1547
38. Gonzalez DD (2001) From evidence-based medicine to medicine-based evidence. An Esp Pediatr 55: 429-439
39. Gray G (2003) Concise guide to evidence-based psychiatry. American Psychiatric Publishing, Washington
40. Grell L (2006) Ist der Beschluss des Bundesverfasssungsgerichts der Abschied von der evidenzbasierten Medizin? MMW-Fortschritte der Medizin 148: 103-106
41. Grimshaw J, Eccles M, Thomas R et al. (2006) Toward evidence-based quality improvement. Evidence (and its limitations) of the effectiveness of guideline dissemination and implementation strategies 1966-1998. J Gen Intern Med (Suppl 2) 21: S14-S20
42. Grimshaw JM, Thomas RE, MacLennan G et al. (2004) Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 8: iii-72
43. Grunze H, Kasper S, Goodwin G et al. (2002) World Federation of Societies of Biological Psychiary (WFSBP) guidelines for biological treatment of bipolar disorders, Part I: Treatment of bipolar depression. World J Biol Psychiatry 3: 115-124
44. Grunze H, Kasper S, Goodwin G et al. (2003) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, Part II: Treatment of mania. World J Biol Psychiatry 4: 5-13
45. Grunze H, Kasper S, Goodwin G et al. (2004) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, Part III: Maintenance treatment. World J Biol Psychiatry 5: 120-135
46. Guyatt G, Gutterman D, Baumann MH et al. (2006) Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest 129: 174-181
47. Harter M, Bermejo I, Schneider F et al. (2003) Umfassendes ambulantes Qualitätsmanagment in der Versorgung depressiver Patienten. Z Arztl Fortbild Qualitatssich (Suppl 4) 97: 9-15
48. Heerdink ER, Stolker JJ, Meijer WEE et al. (2004) Need for medicine-based-evidence in pharmacotherapy. Br J Psychiatry 184: 452-456
49. Hegerl U, Plattner A, Moller HJ (2004) Should combined pharmaco- and psychotherapy be offered to depressed patients? A qualitative review of randomized clinical trials from the 1990 s. Eur Arch Psychiatry Clin Neurosci 254: 99-107
50. Helmchen H (2002) Evidenz der Evidenzbasierten Medizin? Der Nervenarzt 73: 1-2
51. Hirschfeld RMA, Montgomery SA, Aguglia E et al. (2002) Partial response and nonresponse to antidepressant therapy: current approaches and treatment options. J Clin Psychiatry 63: 826-837
52. Höffler D, Lasek R, Tiaden JD (2001) Handlungsleitlinie Demenz Arzneimittelkommission der Deutschen Ärzteschaft, Arzneiverordnung in der Praxis. Arzneiverordnung in der Praxis Sonderheft
53. Hunink MMG (2004) Does evidence based medicine do more good than harm? BMJ 329: 1051
54. Jadad AR, Phil D, Cook DJ (1998) Methodology and Reports of Systematic Reviews and Meta-analyses-Acomparison of cochrane reviews with articles published in paper-based Journals. JAMA 280: 278-280
55. Jorgensen WA, Hilden J, Gotzsche C (2006) Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. BMJ EPub
56. Kane JM, Honigfeld G, Singer J, Meltzer H (1988) Clozapine in treatment-resistant schizophrenics. Psychopharmacol Bull 24: 62-67
57. Kasper S, Möller HJ (2007) Psychopharmakotherapie: klinisch-empirische Grundlagen. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie und Psychotherapie, 3. Aufl. Springer, Berlin Heidelberg (in Druck)
58. Kawamura T, Tamakoshi A, Wakai K, Ohno Y (1999) Evidence-based medicine and 'The Cochrane Collaboration'. Nippon Koshu Eisei Zasshi 46: 498-506
59. Khan KS, Kunz R, Kleijnen J, Antes G (2004) Systematische Übersichten und Meta-Analysen. Ein Handbuch für Ärzte in Klinik und Praxis sowie Experten im Gesundheitswesen. Springer, Berlin
60. Klein DF (2000) Flawed meta-analyses comparing psychotherapy with pharmacotherapy. Am J Psychiatry 157: 1204-1211
61. Koller M, Lorenz W, Abel U (2006) Methodenvielfalt in der klinischen Forschung. MMW-Fortschritte der Medizin 148: 85-91
62. Kopp I, Encke A, Hartig S et al. (2005) Zur Empirie hochwertiger Leitlinien im System der Arbeitsgemeinschaft Wissenschaftlicher Medizinischer Fachgesellschaften (AWMF): Gibt es sie und wie viele? Deutsche Gesellschaft für Chirurgie - Mitteilungen 1: 21-29
63. Kunz R, Ollenschläger G, Raspe H et al. (2000) Lehrbuch Evidenzbasierte Medizin in Klinik und Praxis. Dt Ärzte-Verlag, Köln
64. Laux G (2007) Guidelines - Leitlinen - Algorithmen. Ein aktuelles klinisches Resümee. Psychiatr Prax 34: S148-S150
65. Letmaier M, Schreinzer D, Thierry N et al. (2004) Medikamentöse Behandlung akuter Manien. Eine retrospektive Datenanalyse stationärer Patienten von 1997 bis 1999. Der Nervenarzt 75: 249-257
66. Lieberman JA, Greenhouse J, Hamer RM et al. (2005) Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy. Neuropsychopharmacology 30: 445-460
67. Lieberman JA, Stroup TS, McEvoy JP et al. (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353: 1209-1223
68. Linden M (2002) Verhaltenstherapie: theoretische und empirische Grundlagen sowie klinische Anwendungsprinzipien. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie & Psychotherapie. Springer, Berlin Heidelberg New York, S 681-710
69. Lockwood DNJ, Armstrong M, Grant AD (2004) Integrating evidence based medicine into routine clinical practice: seven years' experience at the hospital for tropical diseases, London. BMJ 329: 1020-1023
70. Lohr KN (2004) Rating the strength of scientific evidence: relevance for quality improvement programs. Int J Qual Health Care 16: 9-18
71. Manser R, Walters EH (2001) What is evidence-based medicine and the role of the systematic review: the revolution coming your way. Monaldi Arch Chest Dis 56: 33-38
72. Moher D, Cook DJ, Eastwood S et al. (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 354: 1896-1900
73. Möller HJ, Laux G, Naber D (2005) Kosten und Effekte von Risperidon in Depotform. Vergleich mit oralen Atypika und konventionellen Depotformulierungen in der Therapie von Schizophreniepatienten in Deutschland. Psychopharmakotherapie 12: 183-192
74. Möller HJ (2000) State of the art of drug treatment of schizophrenia and the future position of the novel/atypical antipsychotics. World J Biol Psychiatry 1: 204-214
75. Möller HJ (2004) Therapieresistenz auf Antidepressiva. Definition, Häufigkeit, Prädiktoren und Interventionsmöglichkeiten. Der Nervenarzt 5: 499-512
76. Möller HJ (2007) Methodik empirischer Forschung und evidenz-basierter Medizin in der Psychiatrie. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie und Psychotherapie. 3. Aufl. Springer Verlag, Berlin Heidelberg (in Druck)
77. Möller HJ, Fuger J, Kasper S (1993) Statistische Metaanalyse der Wirksamkeit neuerer Antidepressiva. In: Antidepressiva und Phasenprophylaktika. Springer, Wien, S 252-256
78. Möller HJ, Gaebel W, Naber D, Rüther E (2006) Atypische Antipsychotika in Deutschland. Eine Bestandsaufnahme. Psychopharmakotherapie 13: 164-168
79. Möller HJ, Grunze H (2000) Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? Eur Arch Psychiatry Clin Neurosci 250: 57-68
80. Möller HJ, Grunze H, Broich K (2006) Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review. Eur Arch Psychiatry Clin Neurosci 256: 1-16
81. Nierenberg AA, Fava M, Trivedi MH et al. (2006) A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry 163: 1519-1530
82. Ollenschlager G, Berenbeck C, Low A et al. (2002) [The National Program for disease management - guidelines under the auspices of the German Medical Association-a method report]. Z Arztl Fortbild Qualitatssich 96: 545-548
83. Ollenschlager G, Helou A, Kostovic-Cilic L et al. (1998) Checklist for methodological quality of guidelines. A contribution to quality promotion of medical guidelines. Z Arztl Fortbild Qualitatssich 92: 191-194
84. Pfaff H (2005) Konzept und Methodik der Versorgungsforschung. Die Psychiatrie 2: 101-106
85. Phillips B, Ball C, Sackett D et al. (2001) Oxford Centre for Evidence-based Medicine Levels of Evidence. Levels of evidence and grades of recommendation. www.cebm net/levels_of_evidenceasp 2001
86. Pilling S, Price K (2006) Developing and implementing clinical guidelines: lessons from the NICE schizophrenia guideline. Epidemiol Psichiatr Soc 15: 109-116
87. Rush AJ, Trivedi MH, Wisniewski SR et al. (2006) Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 354: 1231-1242
88. Sackett DL (2000) Evidence-Based Medicine: How to practice and teach EBM. Churchill Livingstone, New York
89. Sackett DL, Richardson S, Rosenberg WS et al. (1999) Evidenzbasierte Medizin. Zuckschwerdt, München
90. Schmacke N (2006) Evidenzbasierte Medizin und Psychotherapie: die Frage nach den angemessenen Erkenntnismethoden. Psychother Psychosom Med Psychol 56: 202-209
91. Schöchlin C, Möller HJ, Engel RR (2002) Meta-Analysen von Antidepressiva-Studien. In: Riederer P, Laux G, Pöldinger W (Hrsg) Neuro-Psychopharmaka, Bd 3, 2. Aufl. Springer, Wien New York, S 349-363
92. Sheiner LB (1997) Learning versus confirming in clinical drug development. Clin Pharmacol Ther 61: 275-291
93. Trivedi MH, Fava M, Wisniewski SR et al. (2006) Medication augmentation after the failure of SSRIs for depression. N Engl J Med 354: 1243-1252
94. Trivedi MH, Rush AJ, Wisniewski SR et al. (2006) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 163: 28-40
95. Wampold BE, Minami T, Baskin TW, Callen TS (2002) A meta-(re)analysis of the effects of cognitive therapy versus 'other therapies' for depression. J Affect Disord 68: 159-165
96. Weinmann S (2006) Evidenzbasierte Psychiatry. Methoden und Anwendungen. Kohlhammer, Stuttgart
97. Lehmann AF, Steinwachs DM (1998) Translating research into practice: the Schizophrenia Patient Outcome Research Team (PORT) treatment recommendations. Schizophr Bull 24: 1-10